Any confirmation hearings for a new NIH director almost certainly would focus attention on the stem cell issue. Although congressional threats to prohibit NIH funding of research involving human stem cells did not materialize last year, the issue is likely to be revived when the NIH completes work on its stem cell research guidelines. The public comment